Surgical strategy for the treatment of medullary thyroid carcinoma

被引:107
|
作者
Fleming, JB
Lee, JE
Bouvet, M
Schultz, PN
Sherman, SI
Sellin, RV
Friend, KE
Burgess, MA
Cote, GJ
Gagel, RF
Evans, DB
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Sect Endocrine Tumor Surg, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Med Specialties Endocrinol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Med Oncol, Houston, TX 77030 USA
关键词
D O I
10.1097/00000658-199911000-00013
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To evaluate surgical complications, patterns of lymph node metastases, and calcitonin response to compartment-oriented lymphadenectomy in patients with primary or recurrent; medullary thyroid carcinoma (MTC). Summary Background Data The majority of patients with invasive MTC have metastasis to regional lymph nodes at the time of diagnosis, as evidenced by the frequent finding of persistently elevated calcitonin levels after thyroidectomy and the high rates of recurrence in the cervical lymph nodes reported in retrospective studies. These data have provided the rationale for surgeons to perform a more extensive lymphadenectomy at the time of initial thyroidectomy and to consider reoperative cervical lymphadenectomy in patients with persistently elevated calcitonin levels after thyroidectomy. Methods Forty patients underwent surgery for MTC from 1991 to 1997 (23 sporadic cases, 17 familial cases). Patients were divided into three groups based on whether they had undergone previous thyroidectomy and on the results of standardized staging studies performed after referral to the authors' institution. Group 1 (11 patients) had received no previous surgery; group 2 (13) underwent thyroidectomy before referral and had an elevated calcitonin level without radiologic evidence of local-regional or distant metastases; and group 3 (16) underwent thyroidectomy before referral and had an elevated calcitonin level with radiologic evidence of local-regional recurrence. The central neck compartment was dissected in all patients; preoperative staging and the extent of previous surgery dictated the need for lateral (modified radical) neck dissection. After primary or reoperative surgery, calcitonin levels were assessed. Results All patients had major reductions in postoperative calcitonin levels. Seven (29%) of 24 patients in groups 1 and 2 achieved normal calcitonin values compared with only 1 (8%) of 16 in group 3. Postoperative complications included seven cases (17%) of permanent hypoparathyroidism; five (71%) of these occurred in group 3. There were no iatrogenic recurrent laryngeal nerve injuries; one patient required recurrent nerve resection to achieve complete tumor extirpation. At a median follow-up of 35 months, local recurrence was documented in 5 (13%) of 40 patients. Conclusions Compartment-oriented lymphadenectomy performed early in the course of MTC is safe and may return calcitonin levels to normal in up to 25% of carefully selected patients. However, reoperation for bulky cervical disease (group 3) rarely results in normal calcitonin levels and is associated with a high incidence of permanent hypoparathyroidism.
引用
收藏
页码:697 / 707
页数:11
相关论文
共 50 条
  • [1] Surgical treatment of sporadic medullary thyroid carcinoma: strategy and outcome
    Misso, C.
    Calzolari, F.
    Puxeddu, E.
    Lucchini, R.
    Monacelli, M.
    d'Ajello, F.
    Giammartino, C.
    d'Ajello, M.
    Ragusa, M.
    Avenia, N.
    GIORNALE DI CHIRURGIA, 2008, 29 (11-12): : 475 - 478
  • [2] Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience
    Lupone, G.
    Antonino, A.
    Rosato, A.
    Zenone, P.
    Iervolino, E. M.
    Grillo, M.
    De Palma, M.
    GIORNALE DI CHIRURGIA, 2012, 33 (11-12): : 395 - 399
  • [3] Surgical treatment of medullary thyroid carcinoma
    Cohen, MS
    Moley, JF
    JOURNAL OF INTERNAL MEDICINE, 2003, 253 (06) : 616 - 626
  • [4] Surgical treatment of medullary carcinoma of the thyroid
    Favia, G
    Lumachi, F
    TUMORI, 2001, 87 (04) : S49 - S51
  • [5] The surgical treatment of medullary thyroid carcinoma
    Evans, DB
    Fleming, JB
    Lee, JE
    Cote, G
    Gagel, RF
    SEMINARS IN SURGICAL ONCOLOGY, 1999, 16 (01): : 50 - 63
  • [6] SURGICAL STRATEGY IN NONFAMILIAL MEDULLARY-THYROID CARCINOMA
    BRAUN, J
    RAGUSE, T
    AKTUELLE CHIRURGIE, 1982, 17 (03): : 77 - 81
  • [7] Medullary thyroid carcinoma: surgical treatment advances
    Dionigi, Gianlorenzo
    Tanda, Maria Laura
    Piantanida, Eliana
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2008, 16 (02): : 158 - 162
  • [8] SURGICAL-TREATMENT OF MEDULLARY CARCINOMA OF THE THYROID
    BLOCK, MA
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1990, 23 (03) : 453 - 473
  • [9] Medullary thyroid carcinoma: surgical treatment advances
    Dionigi, Gianlorenzo
    Bianchi, Veronica
    Rovera, Francesca
    Boni, Luigi
    Piantanida, Eliana
    Tanda, Maria Laura
    Dionigi, Renzo
    Bartalena, Luigi
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (06) : 877 - 885
  • [10] Surgical and combined treatment of medullary thyroid carcinoma
    Brzhesovskiy, VJ
    Shental, VV
    Lioubaev, VL
    Somasundaram, S
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 218 - 218